Xeljanx, the oral rheumarthritis drug, will receive the insurance benefit from this March
It will now be available to manage rheumarthritisonly with oral drugs2 times.
The Ministry of Health and Welfare had made an administrative notice for the amendment of ‘details regarding application standard and method on medical care expenses’ including information of the Pfizer’s janus kinase ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
